IP Library Granted Patent US 10,669,582
Granted Patent B2
US 10,669,582 · App. 15/915,983 · Granted Jun 2, 2020

Massive parallel method for decoding DNA and RNA

Inventors: Jingyue Ju (Englewood Cliffs, NJ); Zengmin Li (Flushing, NY); John Robert Edwards (St. Louis, MO); Yasuhiro Itagaki (New York, NY)
Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
C12Q1/6869C07H19/10C07H19/14C07H21/00C12Q1/68C12Q1/686C12Q1/6872C12Q1/6874C12Q1/6876C07B2200/11C12Q2525/117C12Q2525/186C12Q2535/101C12Q2535/122C12Q2563/107C12Q2565/501C40B40/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,669,582
App. No.
15/915,983
Granted
Jun 2, 2020
Kind
B2
Abstract

This invention provides methods for attaching a nucleic acid to a solid surface and for sequencing nucleic acid by detecting the identity of each nucleotide analogue after the nucleotide analogue is incorporated into a growing strand of DNA in a polymerase reaction. The invention also provides nucleotide analogues which comprise unique labels attached to the nucleotide analogue through a cleavable linker, and a cleavable chemical group to cap the —OH group at the 3′-position of the deoxyribose.

Claims (10)

1. A deoxyribonucleic acid having attached by a phosphodiester bond at its 3′ end, a deoxyribonucleotide analogue having any one of the following structures:

wherein the O α is the 0 atom at the 3′ end of the deoxyribonucleic acid, and the wavy line represents the remainder of the deoxyribonucleic acid that is 5′ relative to the O α atom;

wherein R (a) represents a small, chemically cleavable, chemical group capping the oxygen at the 3′ position of the deoxyribose of the deoxyribonucleotide analogue, and (b) does not contain a ketone group;

wherein OR is not a methoxy group, an ester group or an allyl ether group;

wherein Tag represents a detectable fluorescent moiety;

wherein Y represents a chemically cleavable, chemical linker;

wherein the deoxyribonucleic acid:

i) produces a 3′—OH group on the deoxyribose of the deoxyribonucleotide analogue upon cleavage of R, and

ii) no longer includes a tag on the base upon cleavage of Y and wherein if the deoxyribonucleotide analogue is: (A), it is capable of forming hydrogen bonds with cytosine or a cytosine nucleotide analogue; (B), it is capable of forming hydrogen bonds with thymine or a thymine nucleotide analogue; (C), it is capable of forming hydrogen bonds with guanine or a guanine nucleotide analogue; or (D), it is capable of forming hydrogen bonds with adenine or an adenine nucleotide analogue.

2. The deoxyribonucleic acid of claim 1 , wherein the allyl ether group is O—CH 2 CH═CH 2 .

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 31, 2018
From: COLUMBIA UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 046993/0191 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2018
From: JU, JINGYUE; LI, ZENGMIN; EDWARDS, JOHN ROBERT; ITAGAKI, YASUHIRO
To: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
Reel/Frame 045573/0874 →
Continuity (11)
Continuation 14670748 · Mar 27, 2015
Continuation 13959660 · Aug 5, 2013
Continuation 13672437 · Nov 8, 2012
Continuation 13339089 · Dec 28, 2011
Continuation 12804284 · Jul 19, 2010
Continuation 11810509 · Jun 5, 2007
Continuation 10702203 · Nov 4, 2003
Division 09972364 · Oct 5, 2001
Continuation In Part 09684670 · Oct 6, 2000
Provisional Application 60300894 · Jun 26, 2001
Related Publication 20180201642A1 · Jul 19, 2018